Phase III Study Comparing Zegerid® With Losec® for the Relief of Heartburn Associated With Gastroesophageal Reflux Disease
NCT01493089
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
239
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastroesophageal Reflux
Interventions
DRUG:
Zegerid
DRUG:
Losec
Sponsor
Norgine